Increasing the usefulness of antibiotics: Treatment of infections caused by gram-negative bacilli.
D000086:Acetazolamide / Q000627:therapeutic use; D000368:Aged; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001639:Bicarbonates / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D003023:Cloxacillin / Q000627:therapeutic use; D004357:Drug Synergism; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D004754:Enterobacter; D004756:Enterobacteriaceae Infections / Q000188:drug therapy* / Q000652:urine; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007612:Kanamycin / Q000627:therapeutic use; D007710:Klebsiella Infections / Q000188:drug therapy / Q000652:urine; D008297:Male; D008875:Middle Aged; D008956:Models, Chemical; D009254:Nafcillin / Q000627:therapeutic use; D010403:Penicillin Resistance; D011511:Proteus / Q000187:drug effects; D012705:Serratia / Q000187:drug effects; D014552:Urinary Tract Infections / Q000188:drug therapy